Implementation Of Track, Trace System For Drug Formulation Exports Extended Till Feb 2024

New Delhi : The government on Friday extended the date for implementation
of the track and trace system for exports of drug formulations till February next year. The decision applies to both non-SSI (Small Scale Industry) and SSI-manufactured drugs.

“The date for implementation of track and trace system for exports of drug formulations with respect to maintaining the parent-child relationship in packaging levels and its uploading on central portal has been extended up to February 1, 2024 for both SSI and non-SSI manufactured drugs,” the Directorate General of Foreign Trade (DGFT) said in a public notice.

Earlier also, the dates have been extended from time to time.

The manufacturer or the exporter of drug formulations would have to print the barcode as per global standards at different packaging levels — primary, secondary and tertiary — to facilitate tracking and tracing of their products.

Barcode helps in tracking and tracing the origin of drugs, which minimises the chances of genuine medicines being considered spurious, sub-standard or counterfeit.

Related Posts

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Lundbeck, a biopharmaceutical company focusing exclusively on brain health, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to asedebart (Lu AG13909), Lundbeck’s novel…

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India, a leader in advanced diagnostic imaging and healthcare technology, has installed and commissioned the Fujifilm Echelon Smart MRI at Jansons Health in Erode. The installation expands access to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure

AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure